Ann Rheum Dis

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Page updated: 18/06/08
Annals of the Rheumatic Diseases
Editorial Board | About ARD | Contact us | Author/Reviewer Guidelines

Aims and Scope
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global
Editorial Board and a growing international readership.

ARD is the official journal of EULAR - the European League Against Rheumatism and all (scientific) delegates to the annual EULAR congress receive a complimentary 12 month subscription to the journal.

Editor

Tore K Kvien

Diakonhjemmet Hospital
Oslo, Norway

Editorial Office Annals of the Rheumatic Diseases
BMJ Journals, BMJPG Ltd
BMA House
Tavistock Square
London, WC1H 9JR
Tel: +44 (0) 20 7383 6250
Fax: +44 (0) 20 7383 6668
Email: ard{at}bmjgroup.com

Frequency 12 times a year plus supplements
Launch date 1939
ISSN ARD 0003-4967
ISSN ARD Online 1468-2044
Readership Clinicians (including trainees) and researchers involved with all areas of rheumatology as well as affiliated healthcare workers such as physiotherapists
Print circulation 9500 (12% UK; 66% Europe (including EULAR delegates); 11% USA & Canada; 3% Far East & Australasia; 9% Rest of World)

Not including online only or consortia customers

Indexed by Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase) Sociedad Iberoamericana de Información Científica (SIIC)
Impact factor The impact 2007 factor is 6.411
Submitting to ARD All papers must be submitted through Bench>Press, our online submission and review system.

ARD welcomes:
Original papers (clinical and basic science; extended and concise reports)
Editorials (usually commissioned)
Review articles (usually commissioned)
Hypothesis articles
Letters to the Editor

ARD will consider rapid review and publication for articles of outstanding interest

In February 2004 ARD launched a "Publish ahead of print" programme for selected articles, which are published online within a few days of acceptance

Supplementary data for articles and electronic correspondence are available on ARD Online

Further information is available in the Instructions to Authors and from the Editorial Office

Lead times Time from submission to first decision: mean 5 weeks
About 22% of submissions are rejected without external peer review
Time from acceptance to print publication: approximately 6 months (original papers)
This journal also features Online First
Acceptance rate 29%
Subscriptions Information on rates and how to subscribe

- Personal print subscribers receive access to ARD Online at no additional cost
- Personal and institutional subscribers may purchase access to ARD Online separately
- All subscribers to ARD receive all supplements
- Subscriptions can start with any issue and refunds are given upon cancellation for outstanding issues
- Non-subscribers may purchase individual articles for US$12 or access the whole site for 30 days for US$30

Rights Authors retain copyright for their own material. However, they must provide ARD with an exclusive licence to publish.
Corresponding authors are provided with a toll-free link to their published article on ARD Online.
Permissions Material may not be reproduced in full or part in any medium or language without prior permission of BMJ Publishing Group Ltd

Please refer to our Copyright and Permission Guidelines

Authors may reproduce their own work in other publications and host on their own website or that of their institution (non-commercial only) without prior permission; we do ask that all material is clearly acknowledged with the original source and a link to the website included where possible

Reprints Reprints contact details
Reprint Order Form

For commercial reprint sales in excess of £2000, BMJ Journals is pleased to offer authors a 10% royalty of net receipts less any sales commission.
The corresponding author will be contacted automatically should such a sale be secured to determine how the royalty should be paid. The royalty will be offered for up to five years after publication.

Royalties from Reprint Sales For commercial reprint sales in excess of £2000, BMJ Journals is pleased to offer authors a 10% royalty of net receipts less any sales commission.
The corresponding author will be contacted automatically should such a sale be secured to determine how the royalty should be paid. The royalty will be offered for up to five years after publication.
Supplements Guidelines for publication of supplements to ARD and other BMJ Journals

For further details please contact Claire Folkes:
Email: cfolkes{at}bmjgroup.com
Tel: +44 (0)20 7383 6057

Advertising For display advertising rates please visit the BMJPG website and/or
contact Euan Currer:
Email: ecurrer{at}bmj.com
Tel: +44 (0)20 7383 6181

For information regarding web advertising and sponsorship of email @lerts
contact Simon Walker
Email: swalker{at}bmj.com
Tel: +44 (0)20 7383 6350

COPE ARD is a member of the Committee on Publication Ethics
Equator Equator
Feedback ARD welcomes feedback on the journal and this site
Related
BMJ Publishing Group sites 
BMJ
Online Learning
British Journal of Sports Medicine
Evidence Based Medicine
Journal of Epidemiology and Community Health
Journal of Medical Ethics
Postgraduate Medical Journal
Quality & Safety in Health Care


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism